4'-Chloro-2,2-dimethyl-2'-fluoropropiophenone, 97.0%, 1g

5-tert-Butyl 2-ethyl 6,7-dihydropyrazolo[1,5-a]pyrazine-2,5(4H)-dicarboxylate, 98%, 1g

5-Bromo-2,4-difluoro-benzamide, 97%, 1g

(triethoxymethoxy)ethane, 97.0%, 5ml

2,3,6-Trifluorobenzaldehyde, 97.0%, 25g

D-(+)-Glucosamine Hydrochloride>98.0%(T)25g

Ethyl 6-Methyl-2-oxo-3-cyclohexene-1-carboxylate (mixture of isomers)>95.0%(GC)1g

Gallium(III) oxide, min. 99.99%, pa, 500 g, plastic packaging.

2,5-Dimethylbenzenesulfonic acid, 97%, 500g

1-(2-methyl-4-nitrophenyl)-5-phenyl-4,5-dihydro-1H-pyrazole-3-carboxylic acid, 95.0%, 1g

BUNAZOSIN, 95%, 250mg

(1-Ethylpiperidin-2-yl)methylamine, 95.0%, 1g

(2E)-1,3-Bis(4-methylphenyl)prop-2-en-1-one, 250mg